DIPENTUM 250 mg, hard capsule 100 capsules
Active ingredients: Olsalazine, Olsalazine sodium
Commercialized according to BDPM
Hard capsule100 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DIPENTUM 250 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène de 100 gélule(s)
- Marketing authorisation holder
- ATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1992
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63634128CIP73330407CIP133400933304072Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OLSALAZINE SODIQUEgélule | 250,00 mg · une gélule | SA |
| OLSALAZINE BASEgélule | 218,23 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.